Boehringer Ingelheim Vetmedica Swine Division is dedicated to providing both effective vaccines and practical, research-proven solutions that prevent disease.
Boehringer Ingelheim developed a non-vitamin K antagonist oral anticoagulant (NOAC) to protect patients with non-valvular atrial fibrillation against stroke